Alzheimer’s Drug Trial Failure Sends Novo Nordisk Stock TumblingBusiness PenNovember 24, 2025 November 24, 2025 Novo Nordisk A/S (NASDAQ: NVO) recently encountered a notable setback that sent ripples through its stock price and raised questions about the company’s strategic direction....
